Cargando…
Editorial: Advances in The Therapy of Atrial Fibrillation: Incrementally Progressive But Not Without Missteps
Advances in the therapy of atrial fibrillation (AF) have not come easily or quickly, despite the recognized need for significantly better antiarrhythmic agents for AF termination and prevention as well as for more user-friendly anticoagulants for the prevention of emboli in patients with AF. Rather,...
Autor principal: | Reiffel, James A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101191/ https://www.ncbi.nlm.nih.gov/pubmed/24821655 http://dx.doi.org/10.2174/1573403X1004140707121644 |
Ejemplares similares
-
COVID-19 Management Missteps
por: Boudi, F Brian, et al.
Publicado: (2022) -
Selected Advancements in the Management of Atrial Fibrillation from the Year 2021
por: Reiffel, James A.
Publicado: (2022) -
Oral Anticoagulation and Antiarrhythmic Drug Therapy for Atrial Fibrillation
por: Reiffel, James A.
Publicado: (2018) -
Atrial fibrillation progression: another step in the RACE to full understanding
por: Capucci, Alessandro, et al.
Publicado: (2023) -
Considerations Regarding the Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation
por: Reiffel, James A.
Publicado: (2018)